Drug Companies Spurned by Supreme Court on Price Negotiation Law
Source: Bloomberg Politics · Bias: Center
Summary
The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments.
Related Coverage
- Billionaire Tech Mogul Peter Thiel Warns Woke AI Company Anthropic Could Rig 2028 Election for Democrats (Far Right — The Gateway Pundit)
- Trump Scores Appeals Court Victory in Battle Over National Park Historical Displays (Right — RedState)
- Big Oil heads for biggest profits in years as Trump pushes for lower gas prices (Right — New York Post)
- Lawfare: Kangaroo court picks fight with state’s conservative attorney general (Far Right — WorldNetDaily)
- UPDATE: Louisiana Supreme Court Temporarily Blocks Politically Motivated Indictment Against AG Liz Murrill (Far Right — The Gateway Pundit)
- This Republican Has a Wild Idea for Fixing Housing Prices: Let the Market Actually Work (Far Right — Townhall)
- Americans hit the road in record numbers for 4th of July — in spite of high gas prices (Right — New York Post)
- Iran’s supreme leader bails on first day of late dad’s funeral ceremonies (Right — New York Post)
Daily Analysis
Read the full Parallax Pulse for May 18, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From May 18, 2026
- Trump's billion-dollar victory could backfire — and end cost him money (Left)
- Who could benefit from Trump's $1.7+ billion "weaponization" fund? (Center)
- Trump’s Push to Defeat Thomas Massie Is the Most Expensive House Primary in Recent Years (Center Left)
- These Republicans are bucking Trump by throwing support behind Thomas Massie (Far Right)
- Voters in six states head to polls with Kentucky’s Massie facing Trump’s fury – US politics live (Center Left)
